Dr. Noor Alnaimy | Johns Hopkins Aramco Healthcare
العربية
Dr. Noor Alnaimy

Dr. Noor Alnaimy

Diagnostic Radiology / Breast Imaging Consultant

Professional Title: Diagnostic Radiology / Breast Imaging Consultant

Specialty: Radiology

Location: Dhahran

Gender: Female

Languages: Arabic, English

Dr. Noor Mohammad Alnaimy is a board‑certified consultant in Diagnostic Radiology and Breast Imaging with over 18 years of experience in women’s imaging. She is highly skilled in mammography, breast ultrasound, contrast‑enhanced mammography (CEM), and breast MRI. She is also an expert in image‑guided interventional breast procedures, including core needle biopsy, fine needle aspiration, marker insertion, and wire localization under mammography, ultrasound, MRI, and stereotactic guidance.

Professional Experience

2023–Present: Consultant, Diagnostic Radiology / Breast Imaging, Johns Hopkins Aramco Healthcare (JHAH), Dhahran, Saudi Arabia

2021–2023: Chairperson, Medical Imaging Department, King Faisal Specialist Hospital (KFSH)

2023: Director, Medical Imaging Service Center, KFSH

2019–2023: Lead, Breast Cancer Early Detection Program, Eastern Health Cluster

2019–2023: Director, May Aljaber Cancer Early Detection Center

2009–2014: Section Head, Breast Imaging, KFSH

Education

King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia

University of British Columbia, Vancouver, Canada

Memberships

2018: Member, Saudi FDA National Diagnostic Reference Level Committee

Sub‑Specialty

Breast Imaging

Medical School

King Faisal University, Dammam, Saudi Arabia

Research Interests

Breast Imaging

Publications

Phase II randomized study assessing efficacy of Capivasertib + Paclitaxel as first‑line treatment

Incidental Finding of Unilateral Diffuse Breast Increased FDG Activity

Imaging of Endometrial Arteriovenous Malformation – RSNA 

Bilateral Breast Fibromatosis – RSNA 

Extra‑abdominal Desmoid Tumor – University of British Columbia

Survival of Patients with Locally Advanced Triple Negative Breast Cancer after Neoadjuvant Platinum‑Containing Chemotherapy 

Neoadjuvant Platinum‑Containing Regimen for Locally Advanced Triple Negative Breast Cancer – ESMO, Annals of Oncology

Pathological Response after Neoadjuvant Chemotherapy and Trastuzumab for HER2‑Positive Breast Cancer

Role of MRI in Diagnosis and Follow‑Up of Breast Cancer – University of Florida

Role of Ultrasonography in Breast Cancer Imaging – PET Clinics

First International Conference in Tumor Imaging – Head of Organizing Committee

Connect

Log in to MyChart